New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Protagonist Therapeutics, Inc.
PTGX
Shape
US Flag

NASDAQ

3B

Biotechnology

Next Earning date - 07 Nov 2024

3B

Biotechnology

Next Earning date - 07 Nov 2024

47.26USD
Shape0.31 ( 0.66%)
favorite-chart

Relative Strenght

30
favorite-chart

Volume Buzz

-53%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

2%

Quote Panel

Shape
Updated October 27, 2024
1W 2.83 % 1M 5.02 % 3M 21.77 % 1Y 230.95 %

Key Metrics

Shape
  • Market Cap

    2.78B


  • Shares Outstanding

    58.90M


  • Share in Float

    55.65M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    47.26


  • Average Volume

    637142


  • Beta

    2.165


  • Range

    13.75-48.323


  • Industry

    Biotechnology


  • Website

    https://www.protagonist-inc.com


  • Sector

    Healthcare


Fundamentals

Shape

18.04x

P/E Ratio

8.72x

P/S Ratio

5.35x

P/B Ratio

0.0

Debt/Equity

53.3%

Net Margin

$2.7

EPS

How PTGX compares to sector?

P/E Ratio

Relative Strength

Shape

PTGX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$167M

Shape3898%

2025-Revenue

$0.57

Shape-13%

2025-EPS

$167M

Shape-340%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Cowen & Co.

initialise

Previous: Not converted

2024-09-24

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.64
vs -0.70

Q4.22

arrow
arrow

N/A

-0.69
vs -0.77

Q1.23

arrow
arrow

N/A

-0.67
vs -0.43

Q2.23

arrow
arrow

N/A

-0.68
vs -0.84

Q3.23

arrow
arrow

N/A

-0.58
vs -0.64

Q4.23

arrow
arrow

+164%

0.44
vs -0.69

Q1.24

arrow
arrow

+587%

3.26
vs -0.67

Q2.24

arrow
arrow

N/A

-0.50
vs -0.68

Q3.24

arrow
arrow

N/A

-0.58
vs -0.58

Q4.24

arrow
arrow

N/A

-0.09
vs 0.44

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-100%

NA  vs 10.3M

Q4.22

arrow
arrow

-100%

NA  vs 8.6M

Q1.23

arrow
arrow

-100%

NA  vs 25.7M

Q2.23

arrow
arrow

-100%

NA  vs 859K

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

60M  vs NA

Q1.24

arrow
arrow

NA

255M  vs NA

Q2.24

arrow
arrow

NA

4.2M  vs NA

Q3.24

arrow
arrow

NA

2.3M  vs NA

Q4.24

arrow
arrow

-26%

44.5M  vs 60M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-12%

-0.12
vs -0.15

Q4.22

arrow
arrow

+6%

0.06
vs -0.12

Q1.23

arrow
arrow

+6%

0.06
vs 0.06

Q2.23

arrow
arrow

-13%

-0.13
vs 0.06

Q3.23

arrow
arrow

+5%

0.05
vs -0.13

Q4.23

arrow
arrow

+8%

0.08
vs 0.05

Q1.24

arrow
arrow

+37%

0.37
vs 0.08

Q2.24

arrow
arrow

-6%

-0.06
vs 0.37

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

133

133
vs 143

-7%

Q4.22

arrow
arrow

142

142
vs 133

7%

Q1.23

arrow
arrow

155

155
vs 142

9%

Q2.23

arrow
arrow

182

182
vs 155

17%

Q3.23

arrow
arrow

146

146
vs 182

-20%

Q4.23

arrow
arrow

159

159
vs 146

9%

Q1.24

arrow
arrow

188

188
vs 159

18%

Q2.24

arrow
arrow

193

193
vs 188

3%

Earnings Growth

Latest News